https://www.marketscreener.com/quote/stock/LUNDBECK-1412962/news/Lundbeck-announced-the-start-of-a-phase-II-clinical-study-to-assess-Lu-AG09222-for-migraine-preventi-37021212/?utm_source=telegram&utm_medium=social&utm_campaign=share